NAD+ IV is a $300–800 longevity industry staple, but the science is more complicated than the marketing. Here's what NAD+ IV actually does, the best clinics and at-home kits in 2026, and whether oral precursors might be the better deal.
Walk into any longevity clinic in Los Angeles, Miami, or New York in 2026 and you'll be offered an NAD+ infusion. The standard protocol — 500 to 1000 mg of intravenous nicotinamide adenine dinucleotide over 2–4 hours — runs $300 to $800 per session. Multi-session packages are common. The marketing suggests dramatic energy improvements, cognitive enhancement, and reversal of biological aging.
The science is more nuanced. NAD+ levels do decline with age, and restoring them does have measurable effects on cellular metabolism. But intravenous infusion is not obviously superior to oral precursors at a fraction of the cost. This guide explains what NAD+ IV actually does, ranks the clinics and at-home options in 2026, and helps you decide whether to spend the money.
Nicotinamide adenine dinucleotide is a coenzyme involved in over 500 enzymatic reactions, most importantly in mitochondrial energy production, DNA repair (via PARP enzymes), and sirtuin activation. Tissue NAD+ levels decline with age — roughly 50% by age 60 in skeletal muscle and brain — driven primarily by increased consumption (chronic inflammation activates NAD+-consuming enzymes like CD38) rather than decreased synthesis.
Restoring NAD+ improves mitochondrial function in mouse models, partially reverses age-related decline in multiple tissues, and (in some animal studies) extends lifespan. The translation question for humans is whether NAD+ restoration produces clinically meaningful benefits — and what's the most efficient way to achieve it.
When you receive 500–1000 mg of NAD+ intravenously, plasma NAD+ rises dramatically during the infusion, then falls back toward baseline within hours. Critically, intracellular NAD+ levels in muscle, liver, and brain do not rise proportionally — most NAD+ is metabolized to nicotinamide before entering cells. Cells preferentially synthesize NAD+ from precursors (NMN, NR, niacinamide) rather than from intact NAD+.
This is a problem for the IV NAD+ thesis. Oral nicotinamide riboside (NR) at 600–1000 mg daily produces sustained 50–70% increases in blood NAD+ levels measurable 24 hours later. NMN at 500–1000 mg does similar. IV NAD+ produces a sharper transient peak but lower sustained intracellular delivery.
What IV NAD+ does seem to do well: subjective effects during the infusion. Many users report sustained mood, mental clarity, and a sense of vitality lasting hours to days after. Whether this is direct NAD+ effect or some combination of placebo plus rest plus IV fluids is unclear from the limited research.
There are very few randomized controlled trials of IV NAD+ for healthspan endpoints. The most-cited work:
In contrast, the oral NR/NMN literature includes multiple double-blind randomized trials in older adults showing sustained NAD+ elevation, modest improvements in walking speed, and consistent improvements in inflammatory markers.
If you're going to do IV NAD+, choose a clinic that:
1. Uses pharmaceutical-grade NAD+ from compounding pharmacies with verified third-party testing
2. Performs medical evaluation including cardiovascular history (NAD+ infusion can cause chest pressure and tachycardia)
3. Infuses slowly (2–4 hours) — fast infusion causes nausea and discomfort
4. Provides peer-reviewed literature on what to expect
Among national clinic chains, the most consistent quality (anecdotally) is delivered by clinics that operate as physician-led longevity practices rather than IV bars. Expect $400–700 for a single 500 mg infusion, $1,200–2,500 for a 4-session "loading" protocol.
Several at-home alternatives are now available:
Companies such as Olympia and EmpowerPharmacy offer prescribed subcutaneous NAD+ injection kits — vials of NAD+ shipped to your home for self-injection. Doses are typically 100–300 mg per injection, given 2–3 times per week. Cost: $200–400/month. The pharmacokinetics are between oral and IV — better absorption than oral, less peak than IV.
Lower-dose, faster-onset alternative. Some clinical use in cognitive endpoints. Cost: $80–150/month.
The cheapest, best-evidenced option. 500–1000 mg NMN or 600–1000 mg NR daily produces sustained NAD+ elevation. Cost: $40–120/month. See our Best NMN Supplements 2026 for brand picks and our NMN vs NR comparison for which to choose.
| Option | Monthly Cost | Sustained NAD+ Elevation | Convenience | Evidence |
| --- | --- | --- | --- | --- |
| IV NAD+ (weekly) | $1,600–3,200 | No (transient peaks) | Low | Weak human data |
| Subcutaneous NAD+ (3x/week) | $200–400 | Moderate | Medium | Limited |
| Intranasal NAD+ | $80–150 | Low-moderate | High | Very limited |
| Oral NR 1000 mg daily | $60–120 | Yes (50–70% elevation) | High | Multiple RCTs |
| Oral NMN 1000 mg daily | $40–100 | Yes (50–60% elevation) | High | Multiple RCTs |
The honest case for IV NAD+ is narrow:
For most longevity-focused users, oral NR or NMN at therapeutic doses delivers comparable or superior NAD+ elevation at 5–10% the cost.
IV NAD+ side effects (during infusion): chest pressure, nausea, headache, sense of impending doom (the "NAD+ flush" — usually dose-dependent and resolved by slowing the infusion). Long-term side effects of repeated IV NAD+ in healthy populations are not well-characterized; theoretical concerns about cancer risk in people with active or undiagnosed malignancy mean a pre-treatment screen is appropriate.
For the broader NAD+ landscape see our NAD+, NMN, and NR overview and Injectable NR vs Oral NAD+ Precursors.
Will I feel anything from oral NMN or NR?
Subjective changes are usually subtle. Look for objective markers: improved walking speed, modest weight loss, improved sleep quality, lower CRP. These take 8–12 weeks.
Is NAD+ IV safe during pregnancy?
No. Avoid all NAD+ interventions during pregnancy and breastfeeding.
Do I need to do an IV "loading dose" before going to oral?
There is no compelling evidence that loading is necessary. Oral precursors raise NAD+ progressively over 2–4 weeks of consistent dosing.